The ARChives

News & Blog

NRC 8.39 Rev 2: Proposed Changes and What you Need to Know

By Dustin Osborne • August 14, 2026
Abstract dark-blue tech interface with orbiting dots and a small login panel on the right.

PSMA Therapy at Diagnosis: What Pluvicto's New Approval Means for the Corridor

By Dustin Osborne • August 7, 2026

What I told Administrators at AHRA 2026

By Dustin Osborne • July 17, 2026

We Hold These Thresholds to Be Self-Evident: What the NRC's Proposed Rule Changes for Patient Release

By Dustin Osborne • July 2, 2026

Two Meetings, One Message: SNMMI + ASCO

By Dustin Osborne • June 13, 2026

Why SNMMI Matters Even if you Aren't Attending

By Dustin Osborne • May 30, 2026
SNMMI 2026: Los Angeles

2nd ARC Workshop: Roanoke and the Future of Theranostics

By Dustin Osborne • May 22, 2026

What is Dosimetry? And Why Does it Matter for Patients in Appalachia?

By Dustin Osborne • May 8, 2026

1st Inaugural ARC Workshop - What We Learned!

By Dustin Osborne • April 24, 2026
What did we learn from our first workshop? Check out this week's blog post to see whether our first workshop was successful or not. Drop your comments at the bottom of the blog or reach out on our contact page.
a graphic depicting a large number of charts titled a completely normal number of charts

A Completely Normal Number of Charts

By Dustin Osborne • April 7, 2026
ARC maps cancer disparities across Appalachia: higher mortality, weaker screening and survival, and major theranostics access and workforce gaps.
Show More